| UniProt ID | EYA3_HUMAN | |
|---|---|---|
| UniProt AC | Q99504 | |
| Protein Name | Eyes absent homolog 3 | |
| Gene Name | EYA3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 573 | |
| Subcellular Localization | Cytoplasm . Nucleus . Localizes at sites of DNA damage at double-strand breaks (DSBs) (PubMed:19234442). With decreasing efficiency, translocalized to the nucleus by SIX2 and SIX5, and SIX4, respectively (By similarity). | |
| Protein Description | Tyrosine phosphatase that specifically dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Promotes efficient DNA repair by dephosphorylating H2AX, promoting the recruitment of DNA repair complexes containing MDC1. [PubMed: 19234442] | |
| Protein Sequence | MEEEQDLPEQPVKKAKMQESGEQTISQVSNPDVSDQKPETSSLASNLPMSEEIMTCTDYIPRSSNDYTSQMYSAKPYAHILSVPVSETAYPGQTQYQTLQQTQPYAVYPQATQTYGLPPFGALWPGMKPESGLIQTPSPSQHSVLTCTTGLTTSQPSPAHYSYPIQASSTNASLISTSSTIANIPAAAVASISNQDYPTYTILGQNQYQACYPSSSFGVTGQTNSDAESTTLAATTYQSEKPSVMAPAPAAQRLSSGDPSTSPSLSQTTPSKDTDDQSRKNMTSKNRGKRKADATSSQDSELERVFLWDLDETIIIFHSLLTGSYAQKYGKDPTVVIGSGLTMEEMIFEVADTHLFFNDLEECDQVHVEDVASDDNGQDLSNYSFSTDGFSGSGGSGSHGSSVGVQGGVDWMRKLAFRYRKVREIYDKHKSNVGGLLSPQRKEALQRLRAEIEVLTDSWLGTALKSLLLIQSRKNCVNVLITTTQLVPALAKVLLYGLGEIFPIENIYSATKIGKESCFERIVSRFGKKVTYVVIGDGRDEEIAAKQHNMPFWRITNHGDLVSLHQALELDFL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEEEQDLP -------CHHCCCCC | 15.33 | 19413330 | |
| 13 | Acetylation | DLPEQPVKKAKMQES CCCCCCCCHHHCHHH | 54.41 | 25953088 | |
| 37 | Sumoylation | NPDVSDQKPETSSLA CCCCCCCCCCCCCHH | 50.22 | - | |
| 59 | Phosphorylation | EIMTCTDYIPRSSND CHHHHCCCCCCCCCC | 8.48 | 23879269 | |
| 63 | O-linked_Glycosylation | CTDYIPRSSNDYTSQ HCCCCCCCCCCCCHH | 28.30 | 30059200 | |
| 63 | Phosphorylation | CTDYIPRSSNDYTSQ HCCCCCCCCCCCCHH | 28.30 | 28348404 | |
| 64 | Phosphorylation | TDYIPRSSNDYTSQM CCCCCCCCCCCCHHC | 34.69 | 28348404 | |
| 67 | Phosphorylation | IPRSSNDYTSQMYSA CCCCCCCCCHHCCCC | 16.73 | 27251275 | |
| 77 | Phosphorylation | QMYSAKPYAHILSVP HCCCCCCCEEEEECC | 15.31 | - | |
| 86 | O-linked_Glycosylation | HILSVPVSETAYPGQ EEEECCCCCCCCCCC | 24.14 | 30059200 | |
| 88 | O-linked_Glycosylation | LSVPVSETAYPGQTQ EECCCCCCCCCCCCH | 24.80 | 30059200 | |
| 96 | Phosphorylation | AYPGQTQYQTLQQTQ CCCCCCHHHHHHCCC | 13.57 | - | |
| 173 | Ubiquitination | QASSTNASLISTSST ECCCCCCEEECCCHH | 28.45 | 24816145 | |
| 219 | Ubiquitination | YPSSSFGVTGQTNSD CCCHHCCCCCCCCCC | 5.25 | 24816145 | |
| 226 | Ubiquitination | VTGQTNSDAESTTLA CCCCCCCCHHHCEEE | 57.32 | 24816145 | |
| 226 | Ubiquitination | VTGQTNSDAESTTLA CCCCCCCCHHHCEEE | 57.32 | - | |
| 228 | Ubiquitination | GQTNSDAESTTLAAT CCCCCCHHHCEEEEE | 54.32 | 24816145 | |
| 235 | Phosphorylation | ESTTLAATTYQSEKP HHCEEEEEEECCCCC | 22.04 | 26074081 | |
| 236 | Phosphorylation | STTLAATTYQSEKPS HCEEEEEEECCCCCC | 18.16 | 26074081 | |
| 237 | Phosphorylation | TTLAATTYQSEKPSV CEEEEEEECCCCCCC | 12.99 | 26074081 | |
| 239 | Phosphorylation | LAATTYQSEKPSVMA EEEEEECCCCCCCCC | 36.85 | 26074081 | |
| 243 | Phosphorylation | TYQSEKPSVMAPAPA EECCCCCCCCCCCCH | 35.28 | 26074081 | |
| 255 | Phosphorylation | APAAQRLSSGDPSTS CCHHHHHHCCCCCCC | 34.17 | 25850435 | |
| 256 | Phosphorylation | PAAQRLSSGDPSTSP CHHHHHHCCCCCCCC | 52.38 | 25159151 | |
| 260 | Phosphorylation | RLSSGDPSTSPSLSQ HHHCCCCCCCCCHHC | 46.38 | 29255136 | |
| 261 | Phosphorylation | LSSGDPSTSPSLSQT HHCCCCCCCCCHHCC | 50.47 | 29255136 | |
| 262 | Phosphorylation | SSGDPSTSPSLSQTT HCCCCCCCCCHHCCC | 19.48 | 23401153 | |
| 264 | Phosphorylation | GDPSTSPSLSQTTPS CCCCCCCCHHCCCCC | 40.18 | 29255136 | |
| 266 | Phosphorylation | PSTSPSLSQTTPSKD CCCCCCHHCCCCCCC | 29.80 | 17525332 | |
| 268 | Phosphorylation | TSPSLSQTTPSKDTD CCCCHHCCCCCCCCC | 36.98 | 23401153 | |
| 269 | Phosphorylation | SPSLSQTTPSKDTDD CCCHHCCCCCCCCCH | 20.23 | 30266825 | |
| 271 | Phosphorylation | SLSQTTPSKDTDDQS CHHCCCCCCCCCHHH | 40.86 | 30266825 | |
| 272 | Acetylation | LSQTTPSKDTDDQSR HHCCCCCCCCCHHHH | 66.89 | 26051181 | |
| 272 | Ubiquitination | LSQTTPSKDTDDQSR HHCCCCCCCCCHHHH | 66.89 | 24816145 | |
| 274 | Phosphorylation | QTTPSKDTDDQSRKN CCCCCCCCCHHHHHH | 45.25 | 30266825 | |
| 274 | Ubiquitination | QTTPSKDTDDQSRKN CCCCCCCCCHHHHHH | 45.25 | 24816145 | |
| 278 | Phosphorylation | SKDTDDQSRKNMTSK CCCCCHHHHHHHCCC | 52.82 | 28450419 | |
| 295 | Phosphorylation | GKRKADATSSQDSEL CCCCCCCCCCCCHHH | 29.47 | 30108239 | |
| 296 | Phosphorylation | KRKADATSSQDSELE CCCCCCCCCCCHHHH | 27.94 | 24719451 | |
| 297 | Phosphorylation | RKADATSSQDSELER CCCCCCCCCCHHHHH | 33.38 | 21815630 | |
| 300 | Phosphorylation | DATSSQDSELERVFL CCCCCCCHHHHHEEE | 36.12 | 24719451 | |
| 377 | Ubiquitination | DVASDDNGQDLSNYS CCCCCCCCCCCCCCE | 29.40 | 29967540 | |
| 384 | Ubiquitination | GQDLSNYSFSTDGFS CCCCCCCEEECCCCC | 19.57 | 29967540 | |
| 430 | Ubiquitination | REIYDKHKSNVGGLL HHHHHHHHCCCCCCC | 49.84 | 29967540 | |
| 430 | Methylation | REIYDKHKSNVGGLL HHHHHHHHCCCCCCC | 49.84 | - | |
| 431 | Phosphorylation | EIYDKHKSNVGGLLS HHHHHHHCCCCCCCC | 36.15 | 29396449 | |
| 438 | Phosphorylation | SNVGGLLSPQRKEAL CCCCCCCCHHHHHHH | 24.83 | 19664994 | |
| 462 | Ubiquitination | LTDSWLGTALKSLLL HCHHHHHHHHHHHHH | 27.01 | 29967540 | |
| 469 | Ubiquitination | TALKSLLLIQSRKNC HHHHHHHHHHCCCCC | 3.98 | 29967540 | |
| 472 | Phosphorylation | KSLLLIQSRKNCVNV HHHHHHHCCCCCEEE | 37.92 | 14702039 | |
| 476 | Ubiquitination | LIQSRKNCVNVLITT HHHCCCCCEEEEHHH | 2.36 | 29967540 | |
| 483 | Ubiquitination | CVNVLITTTQLVPAL CEEEEHHHHCHHHHH | 12.92 | 29967540 | |
| 515 | Ubiquitination | YSATKIGKESCFERI CCCCCCCHHHHHHHH | 50.34 | 29967540 | |
| 529 | Ubiquitination | IVSRFGKKVTYVVIG HHHHHCCEEEEEEEC | 39.94 | 29967540 | |
| 546 | Ubiquitination | RDEEIAAKQHNMPFW CCHHHHHHHHCCCEE | 42.97 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 67 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 72 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 77 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 90 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 96 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 105 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 108 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 138 | S | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 157 | S | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 208 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 225 | S | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 237 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 266 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
| 325 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 426 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 438 | S | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 508 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| 532 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 266 | S | Phosphorylation |
| 19234442 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EYA3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| EYA3_HUMAN | EYA3 | physical | 27432908 | |
| MTMR3_HUMAN | MTMR3 | physical | 27432908 | |
| SOAT1_HUMAN | SOAT1 | physical | 27432908 | |
| PTH2_HUMAN | PTRH2 | physical | 27432908 | |
| MTMR2_HUMAN | MTMR2 | physical | 27432908 | |
| GRPE1_HUMAN | GRPEL1 | physical | 27432908 | |
| FHL2_HUMAN | FHL2 | physical | 27432908 | |
| T126A_HUMAN | TMEM126A | physical | 27432908 | |
| SEN34_HUMAN | TSEN34 | physical | 27432908 | |
| STIP1_HUMAN | STIP1 | physical | 27432908 | |
| ANFC_HUMAN | NPPC | physical | 27432908 | |
| TIM21_HUMAN | TIMM21 | physical | 27432908 | |
| CYBP_HUMAN | CACYBP | physical | 27432908 | |
| NDKA_HUMAN | NME1 | physical | 27432908 | |
| THTPA_HUMAN | THTPA | physical | 27432908 | |
| TBP_HUMAN | TBP | physical | 27432908 | |
| DI3L1_HUMAN | DIS3L | physical | 27432908 | |
| CC28A_HUMAN | CCDC28A | physical | 27432908 | |
| STX17_HUMAN | STX17 | physical | 27432908 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Tyrosine dephosphorylation of H2AX modulates apoptosis and survivaldecisions."; Cook P.J., Ju B.G., Telese F., Wang X., Glass C.K., Rosenfeld M.G.; Nature 458:591-596(2009). Cited for: FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PHOSPHORYLATION ATSER-266, AND MUTAGENESIS OF SER-266 AND ASP-309. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, AND MASSSPECTROMETRY. | |